Biotech CureVac BV said on Friday it raised $ 213.3 million on its exit to bag in New York, in which it will be the first jump to the market of a company that is developing a potential vaccine to combat the coronavirus.
–
Biotech CureVac BV said on Friday it raised $ 213.3 million on its exit to bag in New York, in which it will be the first jump to the market of a company that is developing a potential vaccine to combat the coronavirus.
–